Epidemiologic links between drug use and HIV epidemics: an international perspective.
about
Combination implementation for HIV prevention: moving from clinical trial evidence to population-level effectsStatus of HIV and hepatitis C virus infections among prisoners in the Middle East and North Africa: review and synthesisChronic inflammation and the role for cofactors (hepatitis C, drug abuse, antiretroviral drug toxicity, aging) in HAND persistenceHIV among people who inject drugs in the Middle East and North Africa: systematic review and data synthesisDopamine increases CD14+CD16+ monocyte migration and adhesion in the context of substance abuse and HIV neuropathogenesisDopamine receptor activation increases HIV entry into primary human macrophagesPsychometric properties of the World Health Organization Quality Of Life Assessment-Brief in methadone patients: a validation study in northern Taiwan.Modified social ecological model: a tool to guide the assessment of the risks and risk contexts of HIV epidemicsA venue-based approach to reaching MSM, IDUs and the general population with VCT: a three study site in Kenya.Beyond early infant diagnosis: case finding strategies for identification of HIV-infected infants and children.Prevalence and correlates of HIV, syphilis, and hepatitis B and C infection and harm reduction program use among male injecting drug users in Kabul, Afghanistan: A cross-sectional assessment.Prevention and treatment of HIV/AIDS among drug-using populations: a global perspectiveDrug induced increases in CNS dopamine alter monocyte, macrophage and T cell functions: implications for HAND.Drugs of Abuse in HIV infection and neurotoxicity.The urgency of providing comprehensive and integrated treatment for substance abusers with HIVMigrant Workers in Kazakhstan: Gender Differences in HIV Knowledge and Sexual Risk Behaviors.Cross-sectional assessments of participants' characteristics and loss to follow-up in the first Opioid Substitution Therapy Pilot Program in Kabul, Afghanistan.Hepatitis C and HIV incidence and harm reduction program use in a conflict setting: an observational cohort of injecting drug users in Kabul, Afghanistan.Current understanding of HIV-associated neurocognitive disorders pathogenesis.Effects of combination approach on harm reduction programs: the Taiwan experience.Impact of conflict and displacement on risk behaviours amongst people who inject drugs in Kabul, Afghanistan.HIV, Tat and dopamine transmission.Examining the Efficacy of HIV Risk-Reduction Counseling on the Sexual Risk Behaviors of a National Sample of Drug Abuse Treatment Clients: Analysis of Subgroups.Association of age and time of disease with HIV-associated neurocognitive disorders: a Japanese nationwide multicenter study.Human immunodeficiency virus and hepatitis C virus coinfection in Nepal.The role of catecholamines in HIV neuropathogenesis.Kyrgyzstan: still a regional ‘pioneer’ in HIV/AIDS or living on its reputation?
P2860
Q24610019-FEA4F965-F23F-458D-9D43-D7DFC5DEC466Q26745482-494895FB-51DA-43D6-AC21-456F80CD83C3Q26825762-0F57C09A-6B91-4584-9A8C-9A5BED7329D8Q27013667-7F2CD2B6-050B-4591-98C0-F1A61A8F2A27Q27316037-85A0D337-0543-4D3F-B591-BD9EC2EBF0A2Q28543414-B7EA67CC-1B76-4389-B456-DEEE9F46F123Q30578555-E0457FCB-D0BF-4DC8-B006-AB387EFE2BA9Q31117581-79CCBAD5-4413-4477-9014-E7D25A61C7D4Q33631395-3990AAD9-789A-4A04-8F83-7FAEF54E3EF3Q34006876-F8EB85ED-0A4E-4B5D-A976-78E85638FC6BQ34210820-DA2B87E9-5F26-4146-8A3F-16B1CF2963BEQ34780130-89E70E9F-EC25-4DBB-8F51-90A4839974DBQ35000860-BEF5B851-C066-49A4-BC34-F27D6B13DBFEQ35212027-92669331-A84A-4D0C-8825-D672A4FB94BAQ35308404-037B7BFE-BDA1-4869-B73D-8FC9A3DA37AEQ35856079-6300377B-3C02-4EBE-88C9-7475AC42E357Q36024010-0D5B4D12-2331-49B4-9D47-A7205B7E7C32Q36169466-B84643D9-57AA-4199-96C2-2A44705A2A3AQ36932005-539FDE0B-0BC8-4D40-986E-B9D1FF292583Q37064452-09A80F3C-7C42-4BE7-8C08-C9D53A5B6789Q37628668-B018658C-CF2F-4791-8B76-E0AA83353180Q38812005-96A92C70-561C-44FF-8A1B-07D43AB0990FQ40030804-06024CF9-7B7B-4D42-A5D0-F228DCFAE5BBQ41991842-7561DC5B-55E4-4555-9A23-25D9A00D5995Q42265849-AB75DB97-01CD-411A-B9E2-13784058E15EQ53828206-327538A7-E74E-4A6D-954E-25C89ECDCCBCQ57762760-00DC2AA5-81F0-4630-B3CD-A408F78135C8
P2860
Epidemiologic links between drug use and HIV epidemics: an international perspective.
description
2010 nî lūn-bûn
@nan
2010 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Epidemiologic links between drug use and HIV epidemics: an international perspective.
@ast
Epidemiologic links between drug use and HIV epidemics: an international perspective.
@en
type
label
Epidemiologic links between drug use and HIV epidemics: an international perspective.
@ast
Epidemiologic links between drug use and HIV epidemics: an international perspective.
@en
prefLabel
Epidemiologic links between drug use and HIV epidemics: an international perspective.
@ast
Epidemiologic links between drug use and HIV epidemics: an international perspective.
@en
P2093
P1476
Epidemiologic links between drug use and HIV epidemics: an international perspective.
@en
P2093
Alena Peryskina
Andrea L Wirtz
Chris Beyrer
Frangiscos Sifakis
Stefan Baral
P356
10.1097/QAI.0B013E3181F9C0C9
P407
P478
55 Suppl 1
P50
P577
2010-12-01T00:00:00Z